GF
HAE icon

Gabelli Funds’s Haemonetics HAE Stock Holding History

Gabelli Funds’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
15,000
+2,278
+18% +$146K 0.01% 894
2026
Q1 		$717K Sell
12,722
-1,000
-7% -$65.1K ﹤0.01% 974
2025
Q4 		$1.1M Hold
13,722
– – 0.01% 883
2025
Q3 		$669K Buy
13,722
+3,040
+28% +$188K ﹤0.01% 1003
2025
Q2 		$797K Buy
+10,682
New +$707K 0.01% 944
2022
Q3 		– Sell
-6,500
Closed -$424K – 1363
2022
Q2 		$424K Hold
6,500
– – ﹤0.01% 1050
2022
Q1 		$411K Hold
6,500
– – ﹤0.01% 1092
2021
Q4 		$345K Hold
6,500
– – ﹤0.01% 1156
2021
Q3 		$459K Hold
6,500
– – ﹤0.01% 1093
2021
Q2 		$433K Buy
+6,500
New +$460K ﹤0.01% 1095

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gabelli Funds's HAE Position: Q2 2026 in Review

Gabelli Funds increased its Haemonetics (HAE) stake by 18% in Q2 2026, buying an estimated $146K and bringing the position to 15,000 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #894.

Gabelli Funds first reported a position in HAE in Q2 2021 and has held it in 10 quarters since. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Gabelli Funds held 15,000 shares of Haemonetics worth $1.13M as of Q2 2026.
  • Gabelli Funds bought 2,278 Haemonetics shares in Q2 2026, an estimated $146K.
  • Haemonetics made up 0.01% of Gabelli Funds's portfolio in Q2 2026, its #894 holding.
  • Gabelli Funds first reported a position in Haemonetics in Q2 2021 and has held it in 10 quarters since.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.